On-line Education Teaches Physicians About Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Physicians About Skin Cancer

OSUWexnerbloglogo2014 CME Webcast Teaches Physicians About Skin Cancer. In the 215 years since Laennec discovered melanoma, we have learned an enormous amount about this malignancy and how to best treat it. On this CME webcast, we’re going to update you on the latest information. Joining our moderator are two skin cancer specialists from the James Cancer Hospital. Dr. Joal Beane is a surgical oncologist and Assistant Professor of Surgery at the Ohio State University. And Dr. Carlo Contreras is an Associate Professor of Surgery, also from the OSU Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe at least two advantages of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; List the 2 main classes of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; and UNDERSTAND the diagnosis and management of cutaneous melanoma.

You’ll also learn about the following:

  • Subtypes of melanoma
  • Evaluation and diagnosis
  • Indications for referral
  • Role of metastasectomy in advanced melanoma

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Hospital Workplace Safety on Webcast

OSUWexnerbloglogo2014 Learn About Hospital Workplace Safety on Webcast. On this CME webcast, we are going to be examining hospital workplace safety from three vantages points. To discuss hospital safety from the perspective of hospital administrative leadership is the Chief Administrative Officer of the Hospital Division of the OSU Wexner Medical Center, Elizabeth Seely. To discuss the medical staff’s role is Dr. Iahn Gonsenhauser who is a hospitalist and the Chief Quality and Patient Safety Officer for the OSU Wexner Medical Center. And finally to discuss the role of hospital security is Mike Mandelkorn who is the Director of Medical Center Security at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the
significance of workplace violence in health care; DESCRIBE a number of different best practices and approaches an organization can undertake to improve workplace safety.

You’ll also learn about the following:

  • Organizational measures to improve hospital workplace safety
  • What regulatory & accreditation agencies say
  • Hospital security training

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Myelodysplastic Syndromes on Webcast

OSUWexnerbloglogo2014 Learn About Myelodysplastic Syndromes on Webcast. Myelodysplastic syndromes are a group of diseases in which bone marrow cells do not fully mature into normal blood cells, resulting in reduced numbers of blood cells or cytopenias. It is estimated that more than 60,000 Americans have a myelodysplastic syndrome and as our population continues to age, that number will only increase. Joining us today to update us on myelodysplastic syndromes are two specialists in hematology from the Ohio State University. Dr. Katherine Walsh is an Associate Professor of Internal Medicine and Dr. Alice Mims is an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the differential diagnosis and work-up of cytopenias, DESCRIBE the differences in prognosis and treatment between lower and higher risk Myelodysplastic Syndrome; RECOGNIZE clinical presentation of MDS and differential diagnosis; and DESCRIBE treatment recommendations for patients with low and high risk MDS.

You’ll also learn about the following:

  • Presenting signs and symptoms of myelodysplastic syndromes
  • Causes of myelodysplastic syndromes
  • Linalidomide
  • Myelodysplastic syndromes and vaccinations
  • When to be concerned about isolated: Leukopenia, Anemia, and Thrombocytopenia.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.